Nines (AI assets acquired by Sirona Medical)

San Francisco, California, United States  All United States companies → Founded 2018
Imaging AI Specialist
Neurology Oncology Radiology
Neurology AI Oncology AI Radiology & Imaging AI
Series C — $104M

Products

NinesAI
Nines (AI assets acquired by Sirona Medical)
Neurology AI
NinesAI was an FDA-cleared artificial intelligence tool for radiologists, specializing in the triage of critical head CT findings like intracranial hemorrhage and mass effect, and lung nodule measurement. Its AI assets were acquired by Sirona Medical in 2022 and are now integrated into Sirona's RadOS platform.

See all 1 product →

About Nines (AI assets acquired by Sirona Medical)

Sirona Medical is a healthcare AI company that has developed a cloud-native Radiology Operating System (RadOS), also known as the Unify platform, designed to streamline and enhance the workflow for radiologists. This platform integrates traditionally siloed radiology IT applications, including the worklist, viewer, reporter, archive, and AI capabilities, into a single, cohesive workspace. The company’s mission is to empower radiologists by providing AI-powered solutions that simplify complex tasks and amplify their diagnostic output, ultimately aiming to improve efficiency and reduce errors in medical imaging interpretation.

The acquisition of Nines’ AI assets in February 2022 significantly bolstered Sirona Medical’s artificial intelligence offerings. These acquired assets include FDA-cleared medical devices such as NinesMeasure, an AI-powered algorithm for lung nodule analysis, and NinesAI Emergent Triage, which assists in triaging time-critical indications like intracranial hemorrhage and mass effect on CT images. By integrating these advanced AI tools, Sirona Medical aims to accelerate the adoption of AI in radiology by providing context-specific results within a unified platform, further enhancing workflow efficiency and automating data capture and report generation through patented AI technologies, including a radiology-specific large language model.

Focus Areas

AI-powered teleradiology medical imaging analysis triage of emergent conditions intracranial hemorrhage detection mass effect detection lung nodule measurement radiology workflow optimization machine learning in healthcare

Business Intelligence

Key InvestorsAccel, 8VC, Lori Goler, Kim Hammonds, Mark Leslie
PartnershipsMount Sinai Health System (prior to acquisition)
AcquisitionsAcquired by Sirona Medical (AI assets and key personnel) in February 2022.
TechnologyMachine learning algorithms, clinical data pipeline, AI-powered radiology workflow management and analytics tools, analyzes Digital Imaging and Communications in Medicine (DICOM) images.
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

AI-Powered Medical Imaging Analysis
Nines specializes in advanced AI algorithms for analyzing medical images, particularly CT scans. Their technology is designed to identify critical findings and assist radiologists in their diagnostic process.
Triage of Emergent Conditions
The NinesAI Emergent Triage system is FDA-cleared for the automated radiological review of CT Head images to detect time-critical, life-threatening indications, aiding radiologists in prioritizing cases.
Intracranial Hemorrhage Detection
NinesAI is FDA-cleared to assist radiologists in identifying the possible presence of intracranial hemorrhage on head CT scans, a critical condition requiring rapid intervention.
Mass Effect Detection
The NinesAI system is also FDA-cleared for triaging mass effect conditions on head CT scans, being the first company to receive FDA clearance for AI technology that triages mass effect.
Lung Nodule Measurement
NinesMeasure is an FDA-cleared AI-powered tool that accelerates the measurement of lung nodules on chest CT exams, helping radiologists quickly and accurately measure nodule axes and address inter-study consistency.
Radiology Workflow Optimization
Nines' technology, including the Nines Navigatoru2122 worklist and Nines Reading Assistant, focuses on improving radiologist efficiency by reducing non-diagnostic interruptions and providing an 'always-ready' worklist.
Machine Learning in Healthcare
At its core, Nines leverages advanced machine learning engines and a robust clinical data pipeline to develop its AI-powered solutions for radiology.
Physician Tip

For physicians, Nines' AI assets, now integrated into Sirona Medical's RadOS, offer significant advantages. The FDA-cleared algorithms for intracranial hemorrhage and mass effect detection enable faster identification and prioritization of critical cases, potentially leading to quicker diagnoses and interventions for time-sensitive conditions. The lung nodule measurement tool, NinesMeasure, streamlines a often tedious task, improving accuracy and consistency in monitoring respiratory diseases. Overall, the AI-powered workflow optimization tools aim to reduce administrative burdens and non-diagnostic distractions, allowing radiologists to focus more on patient care and potentially mitigating burnout. The integration into a unified platform like RadOS ensures that these AI insights are delivered context-specifically and seamlessly within the radiologist's existing workflow.

The AI assets of Nines, including its FDA-cleared medical devices (NinesMeasure and NinesAI Emergent Triage), clinical data pipeline, machine learning engines, and AI-powered radiology workflow management and analytics tools, have been acquired by Sirona Medical. These assets are being integrated into Sirona's cloud-native Radiology Operating System (RadOS), which is a unified platform combining radiology IT applications such as worklist, viewer, reporting, and AI. This integration aims to break down the silos of traditional radiology applications, allowing AI to leverage underlying data and deliver context-specific results more effectively to radiologists.

Products by Nines (AI assets acquired by Sirona Medical)

1 product in the directory

NinesAI
Nines (AI assets acquired by Sirona Medical)
Neurology AI
NinesAI was an FDA-cleared artificial intelligence tool for radiologists, specializing in the triage of critical head CT findings like intracranial hemorrhage and mass effect, and lung nodule measurement. Its AI assets were acquired by Sirona Medical in 2022 and are now integrated into Sirona's RadOS platform.

What the Web Says

Sirona Medical acquired the AI assets of Nines in February 2022, including FDA-cleared AI models like NinesMeasure (lung nodule measurements) and NinesAI Emergent Triage (intracranial hemorrhage and mass effect triage). This acquisition aimed to integrate Nines' AI capabilities into Sirona's RadOS radiology operating system, which is designed to unify various radiology workflows such as worklist, viewer, reporting, and AI. Sirona Medical's overall mission is to streamline radiologists' workflows and improve efficiency and accuracy in diagnoses through its cloud-native, AI-powered platform.

Overall: Mixed

Strengths

  • Sirona Medical's RadOS platform aims to unify disparate radiology IT systems, reducing complexity and improving efficiency.
  • The integration of Nines' FDA-cleared AI models (NinesMeasure and NinesAI Emergent Triage) enhances diagnostic capabilities for lung nodules and critical head CT findings.
  • Sirona Medical focuses on simplifying radiologists' workflows and empowering them to make faster, more accurate diagnoses.
  • The company is described as supportive and caring towards its employees, offering a good working environment and flexibility.
  • Sirona Medical's platform is designed to be future-proof and addresses the limitations of older, monolithic software architectures in healthcare.
  • The company offers opportunities for innovation in medical software and aims to reduce radiologist burnout.

Limitations

  • Some reviews for Dentsply Sirona (a separate entity, but often confused due to similar names) indicate issues with new products like the Primescan 2 and DS Core, including connectivity problems and disappointing user experience.
  • Older reviews for 'Sirona' (potentially referring to different entities) mention an unhealthy work environment in administrative functions, with large workloads and issues with covering prolonged sick leave.
  • One review for 'Sirona Health' noted a lack of flexibility in changing shifts for telephone triage nurses, despite otherwise positive aspects.
  • The general challenge of integrating AI into existing radiology workflows has been a sticking point for many in the radiology community.
  • There's a general sentiment on Reddit about AI acquisitions being overhyped and not always delivering on promises, though this isn't specifically about Nines/Sirona.
  • Some reviews for 'Sirona Health' indicate average ratings for work-life balance, pay and benefits, job security, and management.

Based on reviews from: Indeed.com, The Imaging Wire, AuntMinnie, Medigy, MedCity News, Applied Radiology, YouTube, PR Newswire, Reddit, Business Insider, Sirona Medical (Careers Page), Sirona Medical (Blogs), Faculty & Research (Harvard Business School)

Last updated: 2026-07-19

Videos

News, demos, and interviews about Nines (AI assets acquired by Sirona Medical).

Loading videos...

Videos load interactively. If none appear, search YouTube for Nines (AI assets acquired by Sirona Medical) →

View all on YouTube

Press & Coverage

PR Newswire
Sirona Medical Acquires Nines and Key Personnel
Sirona Medical announced the acquisition of Nines' AI capabilities, including its clinical data pipeline, machine learning engines, and two FDA-cleared medical devices, along with key personnel. This move aims to integrate Nines' AI-powered algorithms into Sirona's RadOS operating system to enhance radiology workflows.
2022-02
AuntMinnie
AI market churn continues as Sirona buys AI assets from Nines
Sirona Medical acquired the artificial intelligence (AI) division of teleradiology services provider Nines, including its NinesMeasure lung nodule analysis algorithm and NinesAI EmergentTriage algorithm. This acquisition is part of a broader trend of market consolidation within the AI industry.
2022-02
MedCity News
Sirona Medical acquisition of Nines' Radiology's AI division aims to accelerate AI adoption further
Sirona Medical acquired Nines' Radiology AI division, including its clinical data pipeline, machine learning engines, and two FDA-cleared diagnostic products, to accelerate AI adoption. The integration of Nines' tools into Sirona's unified RadOS platform is expected to optimize and deploy AI at scale.
2022-03
Applied Radiology
Sirona Medical Acquires Nines' AI-based Technology
Sirona Medical has acquired Nines' AI capabilities and technology, including FDA-cleared medical devices like NinesMeasure and NinesAI Emergent Triage. These tools will be integrated into Sirona's RadOS to create a unified platform for radiologists.
2022-02
Radiology Business
Radiology IT firm Sirona Medical raises $42M in Series C financing
Sirona Medical secured over $43 million in Series C financing to enhance its cloud-native Unify platform, which combines image viewing, reporting, and AI. The company previously acquired the assets of AI firm Nines in 2022.
2024-11
BioSpace
Sirona Medical partners with RevealDX to transform lung cancer screening with a comprehensive suite of reimbursed AI tools.
Sirona Medical announced a partnership with RevealDX and the integration of Nines' FDA-cleared automated measurement tool to improve lung nodule assessment. This collaboration aims to streamline lung cancer screening workflows and enhance diagnostic quality.
2022-11
PR Newswire
Sirona Medical Expands Rapidly, Signs Nine New Radiology Practices
Sirona Medical announced the addition of nine new radiology practices to its Unify platform, which offers a unified workflow solution including reporting, PACS, diagnostic viewing, and AI capabilities. The platform's rapid adoption highlights its role in streamlining radiology operations.
2024-10
Tracxn
Sirona Medical - 2026 Company Profile, Team, Funding & Competitors
Sirona Medical, an AI-powered cloud-native radiology workflow management software company, has raised a total funding of $99.7M over four rounds, with its latest Series C round in November 2024. The company acquired Nines' AI-based technology in 2023 (note: Tracxn date for Nines acquisition is slightly off from other sources, which state 2022).
2026-03

Frequently Asked Questions

Sirona Medical's RadOS platform integrates Nines' FDA-cleared AI algorithms, including NinesMeasure for semi-automatic lung nodule measurement on chest CTs and NinesAI Emergent Triage for detecting and prioritizing intracranial hemorrhage and mass effect on head CTs. These tools are designed to accelerate diagnoses of certain respiratory diseases and triage time-critical, life-threatening neurological conditions.
Sirona Medical's cloud-native RadOS unifies disparate radiology IT applications like worklist, viewer, reporting, and AI into a single, cohesive platform, streamlining workflows and reducing radiologist burnout. For teleradiology, this platform enables remote access to imaging data, seamless AI integration, and scalability, while also handling security and compliance challenges.
The Nines AI algorithms, NinesMeasure and NinesAI Emergent Triage, received FDA 510(k) clearance prior to their acquisition by Sirona Medical. Sirona Medical's cloud-native platform is built to adhere to critical healthcare compliance standards, including HIPAA, HL7, DICOM, and FHIR, ensuring patient data protection and regulatory alignment.
Sirona Medical's cloud-native platform is designed with advanced security protocols, including encryption for data in transit and at rest, multi-factor authentication, and continuous monitoring, to protect patient data and ensure HIPAA compliance. The platform's unified architecture facilitates seamless integration of AI tools directly into the workflow, eliminating the complexities and risks often associated with integrating disparate systems.
Sirona Medical acquired Nines' AI capabilities and key personnel in February 2022, integrating them into its RadOS platform, which strengthens its AI offerings. Sirona Medical has demonstrated strong financial stability, securing $42 million in Series C financing in November 2024, indicating continued investor confidence and plans for commercial expansion and platform evolution.
Sirona Medical offers a predictable, usage-based cost model for its cloud-native radiology operating system, which helps practices avoid large capital expenditures and refresh cycles. This approach aims to convert fixed infrastructure costs into a more flexible operating expense, allowing for instant scalability with demand.
Sirona Medical emphasizes ongoing customer service and support as a key initiative, especially following its recent Series C financing. Their cloud-native architecture also simplifies deployment, with new capabilities delivered instantly through browser refresh, minimizing disruptive downtime and IT burden.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.